{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:22:28Z","timestamp":1790626948618,"version":"4.1.0"},"reference-count":32,"publisher":"Japanese Association for Laboratory Animal Science","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. Anim."],"published-print":{"date-parts":[[2024]]},"DOI":"10.1538\/expanim.23-0087","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T22:26:31Z","timestamp":1698791191000},"page":"145-153","source":"Crossref","is-referenced-by-count":6,"title":["Ivabradine ameliorates cardiomyopathy progression in a Duchenne muscular dystrophy model rat"],"prefix":"10.1538","volume":"73","author":[{"given":"Ryota","family":"Tochinai","sequence":"first","affiliation":[{"name":"Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Departments of Laboratory Medicine and Cardiology, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeru","family":"Saika","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Fujii","sequence":"additional","affiliation":[{"name":"Laboratory of Biomedical Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Bunkyo-ku, Tokyo 113-8655, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiharu","family":"Tsuru","sequence":"additional","affiliation":[{"name":"Life Science Laboratory, Primetech Corporation, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Sekizawa","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keitaro","family":"Yamanouchi","sequence":"additional","affiliation":[{"name":"Department of Veterinary Physiology, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Kuwahara","sequence":"additional","affiliation":[{"name":"Department of Veterinary Pathophysiology and Animal Health, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"439","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev.  2016;  2016: CD003725.","DOI":"10.1002\/14651858.CD003725.pub4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med.  1991;  325: 293\u2013302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Bourke JP, Watson G, Muntoni F, Spinty S, Roper H, Guglieri M, et al.DMD Heart Protection Study Group. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study. BMJ Open.  2018;  8: e022572.","DOI":"10.1136\/bmjopen-2018-022572"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rhodes J, Margossian R, Darras BT, Colan SD, Jenkins KJ, Geva T, et al. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol.  2008;  29: 343\u2013351.","DOI":"10.1007\/s00246-007-9113-z"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Lechat P, Brunhuber KW, Hofmann R, Kuhn P, Nesser HJ, Slany J, et al. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet.  1999;  353: 9\u201313.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. MacMahon S, Sharpe N, Doughty R, Krum H, Tonkin A, Trotter A, et al. Australia\/New Zealand Heart Failure Research Collaborative Group. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet.  1997;  349: 375\u2013380.","DOI":"10.1016\/S0140-6736(97)80008-6"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kieny P, Chollet S, Delalande P, Le Fort M, Magot A, Pereon Y, et al. Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. Ann Phys Rehabil Med.  2013;  56: 443\u2013454.","DOI":"10.1016\/j.rehab.2013.06.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Seguchi O, Kuroda K, Fujita T, Kumai Y, Nakajima S, Watanabe T, et al. Heart transplantation ameliorates ambulation capacity in patients with muscular dystrophy \u2212 An analysis of 9 cases. Circ J.  2019;  83: 684\u2013686.","DOI":"10.1253\/circj.CJ-18-1060"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell.  1997;  90: 729\u2013738.","DOI":"10.1016\/S0092-8674(00)80533-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Chu V, Otero JM, Lopez O, Sullivan MF, Morgan JP, Amende I, et al. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve.  2002;  26: 513\u2013519.","DOI":"10.1002\/mus.10223"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakamura K, Fujii W, Tsuboi M, Tanihata J, Teramoto N, Takeuchi S, et al. Generation of muscular dystrophy model rats with a CRISPR\/Cas system. Sci Rep.  2014;  4: 5635.","DOI":"10.1038\/srep05635"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sugihara H, Teramoto N, Nakamura K, Shiga T, Shirakawa T, Matsuo M, et al. Cellular senescence-mediated exacerbation of Duchenne muscular dystrophy. Sci Rep.  2020;  10: 16385.","DOI":"10.1038\/s41598-020-73315-6"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sugihara H, Kimura K, Yamanouchi K, Teramoto N, Okano T, Daimon M, et al. Age-dependent echocardiographic and pathologic findings in a rat model with Duchenne muscular dystrophy generated by CRISPR\/Cas9 genome editing. Int Heart J.  2020;  61: 1279\u20131284.","DOI":"10.1536\/ihj.20-372"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Miyamoto M, Tochinai R, Sekizawa SI, Shiga T, Uchida K, Tsuru Y, et al. Cardiac lesions in Duchenne muscular dystrophy model rats with out-of-frame <i>Dmd<\/i> gene mutation mediated by CRISPR\/Cas9 system. J Toxicol Pathol.  2020;  33: 227\u2013236.","DOI":"10.1293\/tox.2020-0018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kimura K, Morita H, Daimon M, Kawata T, Nakao T, Lee SL, et al. Prognostic impact of venous thromboembolism in patients with Duchenne muscular dystrophy: Prospective multicenter 5-year cohort study. Int J Cardiol.  2015;  191: 178\u2013180.","DOI":"10.1016\/j.ijcard.2015.04.244"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, et al. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson.  2013;  15: 107.","DOI":"10.1186\/1532-429X-15-107"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Swedberg K, Komajda M, Bohm M, Investigators S. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study.Lancet.  2010;  376: 875\u2013885.","DOI":"10.1016\/S0140-6736(10)61198-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Geng X, Zhang J, Zhang Y, Hu H, Yang J, Cui W. Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers. Anatol J Cardiol.  2021;  25: 762\u2013773.","DOI":"10.5152\/AnatolJCardiol.2021.90"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Percie du Sert N, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol.  2020;  18: e3000411.","DOI":"10.1371\/journal.pbio.3000411"},{"key":"20","unstructured":"20. Leary S, Underwood W, Anthony R, Cartner S, Grandin T, Greenacre C, et al.The Panel on Euthanasia. AVMA guidelines for the euthanasia of animals: 2020 edition;  2020."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tochinai R, Suzuki K, Nagata Y, Ando M, Hata C, Komatsu K, et al. Cardiotoxic changes of colchicine intoxication in rats: electrocardiographic, histopathological and blood chemical analysis. J Toxicol Pathol.  2014;  27: 223\u2013230.","DOI":"10.1293\/tox.2014-0013"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kuwahara M, Sugano S, Yayou K, Tsubone H, Kobayashi H. Evaluation of a new tail-cuff method for blood pressure measurements in rats with special reference to the effects of ambient temperature. Jikken Dobutsu.  1991;  40: 331\u2013336.","DOI":"10.1538\/expanim1978.40.3_331"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant.  2013;  48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW, et al. Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol.  2015;  36: 561\u2013568.","DOI":"10.1007\/s00246-014-1050-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kimura K, Takenaka K, Ebihara A, Uno K, Morita H, Nakajima T, et al. Prognostic impact of left ventricular noncompaction in patients with Duchenne\/Becker muscular dystrophy\u2013prospective multicenter cohort study. Int J Cardiol.  2013;  168: 1900\u20131904.","DOI":"10.1016\/j.ijcard.2012.12.058"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, et al.DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol.  2018;  17: 347\u2013361.","DOI":"10.1016\/S1474-4422(18)30025-5"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Adorisio R, Calvieri C, Cantarutti N, D\u2019Amico A, Catteruccia M, Bertini E, et al. Heart rate reduction strategy using ivabradine in end-stage Duchenne cardiomyopathy. Int J Cardiol.  2019;  280: 99\u2013103.","DOI":"10.1016\/j.ijcard.2019.01.052"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. De Benedittis G, Della Rosa G, D\u2019Ettorre E, Piscitelli P, Distante A, de Gregorio C. Effect of Ivabradine in dilated cardiomyopathy from Duchenne muscular dystrophy: A chance for slowing progression of heart failure? Int J Cardiol.  2016;  223: 286\u2013288.","DOI":"10.1016\/j.ijcard.2016.08.135"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yamamoto T, Awano H, Zhang Z, Sakuma M, Kitaaki S, Matsumoto M, et al. Cardiac dysfunction in Duchenne muscular dystrophy is less frequent in patients with mutations in the dystrophin Dp116 coding region than in other regions. Circ Genom Precis Med.  2018;  11: e001782.","DOI":"10.1161\/CIRCGEN.117.001782"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Bonnet D, Berger F, Jokinen E, Kantor PF, Daubeney PEF. Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure. J Am Coll Cardiol.  2017;  70: 1262\u20131272.","DOI":"10.1016\/j.jacc.2017.07.725"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Szabo PL, Marksteiner J, Ebner J, Dostal C, Podesser BK, Sauer J, et al. Ivabradine acutely improves cardiac Ca handling and function in a rat model of Duchenne muscular dystrophy. Physiol Rep.  2023;  11: e15664.","DOI":"10.14814\/phy2.15664"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Vilaine JP, Bidouard JP, Lesage L, Reure H, P\u00e9glion JL. Anti-ischemic effects of ivabradine, a selective heart rate-reducing agent, in exercise-induced myocardial ischemia in pigs. J Cardiovasc Pharmacol.  2003;  42: 688\u2013696.","DOI":"10.1097\/00005344-200311000-00016"}],"container-title":["Experimental Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/73\/2\/73_23-0087\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T04:24:44Z","timestamp":1714796684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/expanim\/73\/2\/73_23-0087\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1538\/expanim.23-0087","relation":{},"ISSN":["1341-1357","1881-7122"],"issn-type":[{"value":"1341-1357","type":"print"},{"value":"1881-7122","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23-0087"}}